These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tibolone: cancers of the breast and endometrium. Prescrire Int; 2006 Jun; 15(83):107. PubMed ID: 16764100 [TBL] [Abstract][Full Text] [Related]
6. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer. Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769 [TBL] [Abstract][Full Text] [Related]
7. [Reasons for abandonment of hormone replacement therapy with tibolone in menopausal women]. Zayas-Jaime FJ; Ornelas-Aguirre JM; Pérez-Nápoles DE Ginecol Obstet Mex; 2013 Oct; 81(10):593-601. PubMed ID: 24483042 [TBL] [Abstract][Full Text] [Related]
8. Tibolone: a unique version of hormone replacement therapy. Swegle JM; Kelly MW Ann Pharmacother; 2004 May; 38(5):874-81. PubMed ID: 15026563 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women. Sieuwerts AM; De Napoli G; van Galen A; Kloosterboer HJ; de Weerd V; Zhang H; Martens JW; Foekens JA; De Geyter C Mol Oncol; 2011 Dec; 5(6):504-16. PubMed ID: 21956102 [TBL] [Abstract][Full Text] [Related]
10. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Kenemans P; Speroff L; Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105 [TBL] [Abstract][Full Text] [Related]
11. Tibolone: the way to beat many a postmenopausal ailments. Lazovic G; Radivojevic U; Marinkovic J Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345 [TBL] [Abstract][Full Text] [Related]
12. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Lundström E; Christow A; Kersemaekers W; Svane G; Azavedo E; Söderqvist G; Mol-Arts M; Barkfeldt J; von Schoultz B Am J Obstet Gynecol; 2002 Apr; 186(4):717-22. PubMed ID: 11967497 [TBL] [Abstract][Full Text] [Related]
13. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial. Sismondi P; Kimmig R; Kubista E; Biglia N; Egberts J; Mulder R; Planellas J; Moggio G; Mol-Arts M; Kenemans P Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384 [TBL] [Abstract][Full Text] [Related]
14. Cognitive effects of 10 years of hormone-replacement therapy with tibolone. Fluck E; File SE; Rymer J J Clin Psychopharmacol; 2002 Feb; 22(1):62-7. PubMed ID: 11799344 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Bai W; Henneicke-von Zepelin HH; Wang S; Zheng S; Liu J; Zhang Z; Geng L; Hu L; Jiao C; Liske E Maturitas; 2007 Sep; 58(1):31-41. PubMed ID: 17587516 [TBL] [Abstract][Full Text] [Related]
16. [Relation between hormonal therapy and tibolone with SERMs in postmenopausal women's myomes growth]. Carranza Lira S Ginecol Obstet Mex; 2008 Oct; 76(10):610-4. PubMed ID: 19062511 [TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy use and variations in the risk of breast cancer. Opatrny L; Dell'Aniello S; Assouline S; Suissa S BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598 [TBL] [Abstract][Full Text] [Related]
18. Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK. Plumb JM; Guest JF Pharmacoeconomics; 2000 Nov; 18(5):477-86. PubMed ID: 11151401 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Campisi R; Marengo FD Cardiovasc Drug Rev; 2007; 25(2):132-45. PubMed ID: 17614936 [TBL] [Abstract][Full Text] [Related]
20. Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations. Baber R; Hickey M; Kwik M Drug Saf; 2005; 28(12):1085-100. PubMed ID: 16329712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]